2025 annual financial data
NervGen Pharma 2025 Financial results
Direct answer
Revenue was 0 CAD.
Operating income was -25,079,252 CAD and net income was -44,117,305 CAD.
Operating cash flow was -19,499,211 CAD.
Get free NervGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -25,079,252 CAD
- Net income
- -44,117,305 CAD
- Operating cash flow
- -19,499,211 CAD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all NervGen Pharma financial years